EV Biologics Market Cap

EV Biologics has a market cap or net worth of $511.27 thousand as of April 29, 2026. Its market cap has decreased by -95.40% in one year.

Market Cap

511.27K

Enterprise Value

n/a

Revenue

9.47M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.05

Market Cap Chart

Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 511.27K, a decrease of -99.27%. That is a compound annual growth rate of -36.60%.

Market Cap History

Date	Market Cap	% Change
Apr 16, 2026	511.27K	-38.35%
Dec 31, 2025	829.28K	-15.08%
Dec 31, 2024	976.52K	-90.45%
Dec 20, 2023	10.23M	-56.18%
Dec 28, 2022	23.33M	109.88%
Dec 31, 2021	11.12M	-83.80%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Bio-Path Holdings	521.76K
Regenerative Medical Technology Group	525.56K
CNBX Pharmaceuticals	490.31K
Sorrento Therapeutics	489.34K
Altamira Therapeutics	440.09K
Eloxx Pharmaceuticals	608.63K
Emmaus Life Sciences	624.68K
Actavia Life Sciences	385.91K

Market Cap Rankings